High materiality7/10
DexCom price target raised to $105 from $90 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital raised DXCM price target to $105 from $90; current price is $86.29.
- DXCM target raised to 105 vs 86.29
- RBC upgrade suggests upside potential
Key facts
- 01
Target: $105
- 02
Posted price: $86.29
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.